Hyperhomocysteinemia: how does it affect the development of cardiovascular disease?

Cardoso, Inês Lopes

http://hdl.handle.net/10284/8592

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
IACVD-2-008_Hyperhomocysteinemia.pdf		694.98 KB	Adobe PDF	Download

Send Feedback

Authors

Cardoso, Inês Lopes

Abstract(s)

Homocysteine is an amino acid with an SH group, metabolised by the remethylation and transsulfuration pathways. Several genetic and environmental factors (like deficient nutrition status, systemic disease or consumption of certain drugs), can lead to changes in the levels of plasma homocysteine. Nowadays, hyperhomocysteinemia is considered an important and independent risk factor for atherosclerosis and cardiovascular disease. Several pathological mechanisms have been proposed for the effect of hyperhomocysteinemia in the development of cardiovascular disease. Among them are DNA methylation, decreased protein S-nitrosylation, production of reactive oxidative species and decrease in nitric oxide formation. Main strategies being tested for the treatment of this condition involve supplementation of folic acid, vitamins B6, B12 or riboflavin. From these, increased plasma folic acid levels by folate-rich diet or pharmacological supplementation seems to be the most effective.